167 related articles for article (PubMed ID: 34625644)
41. Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments.
Ozcan G; Singh M; Vredenburgh JJ
Clin Cancer Res; 2023 Jan; 29(1):11-29. PubMed ID: 35972437
[TBL] [Abstract][Full Text] [Related]
42. Unique genomic alterations of cerebrospinal fluid cell-free DNA are critical for targeted therapy of non-small cell lung cancer with leptomeningeal metastasis.
Wang Y; Jiang F; Zhang Y; Li M; Li Y; Li H; Zhao Q; Shi M; Yu Y; Shao YW; Cai H; Miao L; Xia H
Genomics; 2021 Nov; ():. PubMed ID: 34793951
[TBL] [Abstract][Full Text] [Related]
43.
Yang H; Wen L; Zhao C; Li X; Shan C; Liu D; Hong W; Zhou Z; Zhou C; Cai L; Zhou C
Front Oncol; 2022; 12():902664. PubMed ID: 35978803
[TBL] [Abstract][Full Text] [Related]
44. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H
J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649
[TBL] [Abstract][Full Text] [Related]
45. Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis.
Chiang CL; Ho HL; Yeh YC; Lee CC; Huang HC; Shen CI; Luo YH; Chen YM; Chiu CH; Chou TY
J Cancer Res Clin Oncol; 2023 Jan; 149(1):5-14. PubMed ID: 36318332
[TBL] [Abstract][Full Text] [Related]
46. Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment.
Wang Y; Yang X; Li NJ; Xue JX
Lung Cancer; 2022 Dec; 174():1-13. PubMed ID: 36206679
[TBL] [Abstract][Full Text] [Related]
47. Osimertinib for the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer patients with leptomeningeal metastases and different T790M status.
Xu H; Chen H; Kong J; Zhang Y; Liu S; Yang G; Yang L; Wang Y
Ann Transl Med; 2021 Jun; 9(11):937. PubMed ID: 34350252
[TBL] [Abstract][Full Text] [Related]
48. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer.
Nevel KS; DiStefano N; Lin X; Skakodub A; Ogilvie SQ; Reiner AS; Pentsova E; Boire A
Neuro Oncol; 2020 May; 22(5):675-683. PubMed ID: 32352148
[TBL] [Abstract][Full Text] [Related]
49. Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.
Zheng MM; Li YS; Tu HY; Sun H; Yin K; Jiang BY; Yang JJ; Zhang XC; Zhou Q; Xu CR; Wang Z; Chen HJ; Zhou DX; Wu YL
BMC Med; 2022 May; 20(1):197. PubMed ID: 35644609
[TBL] [Abstract][Full Text] [Related]
50. Identification of Cerebrospinal Fluid MicroRNAs Associated With Leptomeningeal Metastasis From Lung Adenocarcinoma.
Pan Z; Yang G; He H; Gao P; Jiang T; Chen Y; Zhao G
Front Oncol; 2020; 10():387. PubMed ID: 32328453
[No Abstract] [Full Text] [Related]
51. Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer.
Chen X; Bai K; Zhang Y; Xu Y; Huo Y; Wang S; Zou Y; Qi X; Guo R; Ou Q; Liu D; Yin S; Chen S; Bu H
J Transl Med; 2023 May; 21(1):296. PubMed ID: 37131253
[TBL] [Abstract][Full Text] [Related]
52. Extracellular Vesicles from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients Deliver MiR-21 and Induce Methotrexate Resistance in Lung Cancer Cells.
Im JH; Lee KY; Seo Y; Rhim J; Dho YS; Yoo BC; Park JB; Shin SH; Yoo H; Kim JH; Gwak HS
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542098
[TBL] [Abstract][Full Text] [Related]
53. Molecular characteristics and prognostic factors of leptomeningeal metastasis in non-small cell lung cancer.
Liu X; Li G; Zhang H; Chang Q; Fang M; Lu C; Tian P; Mei F
Clin Neurol Neurosurg; 2023 Feb; 225():107572. PubMed ID: 36610238
[TBL] [Abstract][Full Text] [Related]
54. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
[TBL] [Abstract][Full Text] [Related]
55. Different Metabolomic and Proteomic Profiles of Cerebrospinal Fluid in Ventricular and Lumbar Compartments in Relation to Leptomeningeal Metastases.
Kwon JW; Im JH; Lee KY; Yoo BC; Lee JH; Kim KH; Kim JH; Shin SH; Yoo H; Gwak HS
Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050202
[TBL] [Abstract][Full Text] [Related]
56. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
[TBL] [Abstract][Full Text] [Related]
57. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay.
Wooster M; McGuinness JE; Fenn KM; Singh VM; Franks LE; Lee S; Cieremans D; Lassman AB; Hershman DL; Crew KD; Accordino MK; Trivedi MS; Iwamoto F; Welch MR; Haggiagi A; Schultz RD; Huynh L; Sales E; Fisher D; Mayer JA; Kreisl T; Kalinsky K
Clin Breast Cancer; 2022 Jun; 22(4):e457-e462. PubMed ID: 34920954
[TBL] [Abstract][Full Text] [Related]
59. Bedside ocular ultrasonography for diagnosing increased intracranial pressure in patients with leptomeningeal metastases from non-small-cell lung cancer.
Jiang C; Lin Y; Li H; Xie Y; Yu T; Feng J; Huang M; Guo A; Shen H; Zhang Y; Yin Z
Cancer Med; 2023 Mar; 12(6):6913-6923. PubMed ID: 36464859
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of molecular characteristics of cerebrospinal fluid for non-small cell lung cancer patients with leptomeningeal metastasis.
Li N; Liu Y; Duan J; Yang B; Bai H; Sun R; Yu L; Wang J
Thorac Cancer; 2019 Aug; 10(8):1673-1682. PubMed ID: 31368671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
